Clinical Trial Update: Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial of transarterial chemoperfusion using cisplatin, methotrexate, and gemcitabine for unresectable pleural mesothelioma has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Malignant Pleural Mesothelioma, Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2023-02-01